154 related articles for article (PubMed ID: 11560564)
1. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
Sørensen HT; Mellemkjaer L; Olsen JH
Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular drugs and the risk of suicide: a nested case-control study.
Callréus T; Agerskov Andersen U; Hallas J; Andersen M
Eur J Clin Pharmacol; 2007 Jun; 63(6):591-6. PubMed ID: 17468865
[TBL] [Abstract][Full Text] [Related]
3. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.
Friis S; Sørensen HT; Mellemkjaer L; McLaughlin JK; Nielsen GL; Blot WJ; Olsen JH
Cancer; 2001 Nov; 92(9):2462-70. PubMed ID: 11745304
[TBL] [Abstract][Full Text] [Related]
5. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
6. Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression.
Dunn NR; Freemantle SN; Mann RD
Br J Clin Pharmacol; 1999 Aug; 48(2):230-3. PubMed ID: 10417501
[TBL] [Abstract][Full Text] [Related]
7. Calcium-channel blockers and risk of cancer.
Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
[TBL] [Abstract][Full Text] [Related]
8. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
[TBL] [Abstract][Full Text] [Related]
9. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
10. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
[TBL] [Abstract][Full Text] [Related]
11. Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study.
Harrison PJ; Luciano S; Colbourne L
J Psychopharmacol; 2020 Aug; 34(8):848-855. PubMed ID: 32638634
[TBL] [Abstract][Full Text] [Related]
12. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
Hallas J; Christensen R; Andersen M; Friis S; Bjerrum L
Br J Clin Pharmacol; 2012 Jul; 74(1):180-8. PubMed ID: 22243442
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
Meier CR; Derby LE; Jick SS; Jick H
Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
15. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
16. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
17. Do calcium channel blockers increase the risk of cancer?
Pahor M; Guralnik JM; Salive ME; Corti MC; Carbonin P; Havlik RJ
Am J Hypertens; 1996 Jul; 9(7):695-9. PubMed ID: 8806983
[TBL] [Abstract][Full Text] [Related]
18. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
19. Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.
Chouchana L; Beeker N; Garcelon N; Rance B; Paris N; Salamanca E; Polard E; Burgun A; Treluyer JM; Neuraz A;
Cardiovasc Drugs Ther; 2022 Jun; 36(3):483-488. PubMed ID: 33595761
[TBL] [Abstract][Full Text] [Related]
20. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]